High Tower Advisors, LLC Chimerix Inc Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.9 - $1.06 $900 - $1,060	-1,000 Reduced 4.94%	19,259 $18,000
Q4 2022 Feb 08, 2023	SELL	$1.67 - $2.35 $4,592 - $6,462	-2,750 Reduced 11.95%	20,259 $37,000
Q3 2022 Nov 09, 2022	SELL	$1.81 - $2.76 $12,670 - $19,320	-7,000 Reduced 23.33%	23,009 $45,000
Q4 2021 Feb 10, 2022	BUY	$5.23 - $7.18 $94,140 - $129,240	18,000 Added 149.89%	30,009 $192,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $71,333 - $105,078	12,009 New	12,009 $74,000
Q1 2021 May 10, 2021	SELL	$4.76 - $11.25 $57,162 - $135,101	-12,009 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.43 - $5.42 $29,181 - $65,088	12,009 New	12,009 $58,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.